NM_000363.5:c.485G>A
Variant summary
The NM_000363.5(TNNI3):c.485G>A (p.Arg162Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.0000322 (AC=47) in the gnomAD database across 1,461,004 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000655. Note: a gnomAD entry for this variant shows a statistical allele-bias signature, consistent with mosaic/somatic contamination (e.g. age-related clonal hematopoiesis) rather than true inherited population frequency — this frequency should not be read as evidence of a common, benign germline variant. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000209175: Published in vitro functional studies using HEK293 cells showed that the R162Q variant results in a 50% reduction of the troponin I and troponin C interaction (Doolan et al., 2005)" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.R162P: Pathogenic/Likely_pathogenic (ClinVar VariationId 43390, 2 stars) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.R162?: Uncertain_significance (ClinVar VariationId 454407, 1 star); p.R162G: Uncertain_significance (ClinVar VariationId 3071848, 1 star); p.R162= (synonymous): Likely_benign (ClinVar VariationId 3231263, 2 stars); p.R162= (synonymous): Likely_benign (ClinVar VariationId 1060070, 1 star); p.R162W: Uncertain_significance (ClinVar VariationId 161396, 3 stars) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_000363.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 7Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- dilated cardiomyopathy 2AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen
- cardiomyopathy, familial restrictive, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- dilated cardiomyopathy 1FFInheritance: AD Classification: STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- familial isolated restrictive cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACMG Germline Pathogenicity v2019
Our verdict: Pathogenic. The variant received 17 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| PS3Functional studies show damaging effect | Well-established functional study supports damaging effect (PS3); SCV000209175: Published in vitro functional studies using HEK293 cells showed that the R162Q variant results in a 50% reduction of the troponin I and troponin C interaction (Doolan et al., 2005); SCV000280508: There is also expertimental evidence that suggests this variant dirupts protein-protein interactions.; SCV000059952: "In vitro functional studies using a mammalian two-hybrid system suggests that this variant may impact protein function by affecting the interaction with other binding partners (troponin T and troponin C;" PMID:15698845); SCV000253837: Experimental studies have shown that this missense change affects TNNI3 function (PMID: 15698845).; SCV004819051: "A functional study has shown that this variant disrupts interactions with troponin C and T (PMID: 15698845)."; SCV001358527: "A functional study has shown that this variant disrupts interactions with troponin C and T (PMID: 15698845)."; SCV000996359: A mammalian two-hybrid system has shown that this missense change decreases troponin T and troponin C interaction (Doolan A, et al., 2005), whereas crystal structure modelling suggests that the Arg162Gln affects troponin C stability (Ramachandran G, et al., 2013). | ||
| PM1Mutational hot spot or critical domain | Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 10 pathogenic, 0 benign (OR vs. background: 105.0). | ||
| PM2Absent/extremely low in population databases | Rare in gnomAD for AD/XL gene (popmax AF below threshold) — PM2 Supporting; GnomAD popmax AF = 0.0000655 — borderline rare for AD+AR gene (threshold 0.0001) — PM2 supporting. | ||
| PM5Novel missense at known pathogenic residue | Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.R162P: Pathogenic/Likely_pathogenic (ClinVar VariationId 43390, 2 stars); Other variants at the same amino acid residue (not pathogenic): p.R162?: Uncertain_significance (ClinVar VariationId 454407, 1 star); p.R162G: Uncertain_significance (ClinVar VariationId 3071848, 1 star); p.R162= (synonymous): Likely_benign (ClinVar VariationId 3231263, 2 stars); p.R162= (synonymous): Likely_benign (ClinVar VariationId 1060070, 1 star); p.R162W: Uncertain_significance (ClinVar VariationId 161396, 3 stars) | ||
| PP5Reputable source reports pathogenic | ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (29/29 total P/LP). |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000363.5. You can select a different transcript below to see updated classification assignments.
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
TNNI3 | TSL:1MANE Select | c.485G>A p.Arg162Gln | missense | Exon 7 of 8 | Prot: ENSP00000341838.5 UniProt: | |
TNNI3 | c.518G>A p.Arg173Gln | missense | Exon 7 of 8 | Prot: ENSP00000499482.1 UniProt: | ||
TNNI3 | c.473G>A p.Arg158Gln | missense | Exon 7 of 8 | Prot: ENSP00000519518.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.00000658 | AC:1 | Hom:0 | AN:152006 | Cov:31 |
GnomAD2 exomes | AF: 0.0000402 | AC:10 | AN:249030 | ||
GnomAD4 exome | AF: 0.0000322 | AC:47 | Hom:0 | AN:1461004 | Cov:32 |
GnomAD4 genome | AF: 0.00000658 | AC:1 | Hom:0 | AN:152006 | Cov:31 |
TOPMed (Bravo) | AF: 0.0000113 | ||||
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000552 | AC:5 | Hom:0 | AN:90516 | |
Local & regional cohorts 3 sources | |||||
ChinaMAP Phase 1 | AF: 0.0000492 | ||||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.00000800 | AC:1 | Hom:0 | AN:122136 | |
Turkish Variome | AF: 0.000647 | AC:1 | Hom:0 | AN:1546 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
BipEx | 0.000106 | 3 | 28420 | 0.0000347 | 1 | 28844 |
Epi25 | 0.0000477 | 2 | 41958 | 0.0000449 | 3 | 66888 |
SCHEMA | 0.0000291 | 3 | 103196 | 0.0000271 | 5 | 184284 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 20 | |
AlphaMissense | Benign | 0.11 | |
BayesDel_addAF | Benign | -0.080 | T |
BayesDel_noAF | Benign | -0.17 | |
CADD | Benign | 23 | |
CardioboostCm | Uncertain | 0.15 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Uncertain | 0.67 | D |
Eigen | Benign | 0.083 | |
Eigen_PC | Uncertain | 0.22 | |
FATHMM_MKL | Benign | 0.61 | D |
FuncVEP CTI | Benign | 0.38 | |
GPN-Star LLR | N/A | -6.4 | |
GPN-Star score | N/A | 6.4 | |
LIST_S2 | Uncertain | 0.93 | D |
M_CAP | Uncertain | 0.16 | D |
MetaRNN | Uncertain | 0.65 | D |
MetaSVM | Uncertain | -0.062 | T |
Mutation Taster | N/A | 14/86 | disease causing (ClinVar) |
MutationAssessor | Benign | 0.83 | L |
PhyloP100 | Uncertain | 4.0 | |
popEVE | Benign | -3.1 | |
PrimateAI | Uncertain | 0.55 | T |
PROVEAN | Benign | -1.1 | N |
RBP_binding_hub_radar | N/A | 0.0 | |
RBP_regulation_power_radar | N/A | 1.7 | |
REVEL | Uncertain | 0.36 | |
Sift | Benign | 0.031 | D |
Sift4G | Benign | 0.063 | T |
Varity_R | N/A | 0.33 | |
VESM-3B | Benign | -7.1 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.0 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.